Milan Stock Exchange:BIT:PHIL

Philogen Provides Corporate Update Nidlegy™ and Fibromun pivotal clinical trials on track Fibromun shows potent activity in last-line glioblastoma in combination with LomustineOncoFAP platform shows promising results in both…